HUP0203470A3 - Treatment of fatigue, head injury and stroke - Google Patents
Treatment of fatigue, head injury and strokeInfo
- Publication number
- HUP0203470A3 HUP0203470A3 HU0203470A HUP0203470A HUP0203470A3 HU P0203470 A3 HUP0203470 A3 HU P0203470A3 HU 0203470 A HU0203470 A HU 0203470A HU P0203470 A HUP0203470 A HU P0203470A HU P0203470 A3 HUP0203470 A3 HU P0203470A3
- Authority
- HU
- Hungary
- Prior art keywords
- fatigue
- stroke
- treatment
- head injury
- injury
- Prior art date
Links
- 206010019196 Head injury Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Finger-Pressure Massage (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9924172A GB2355191A (en) | 1999-10-12 | 1999-10-12 | Combination formulations for fatigue, head injury and strokes |
PCT/GB2000/003926 WO2001026623A2 (en) | 1999-10-12 | 2000-10-12 | Treatment of fatigue, head injury and stroke |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0203470A2 HUP0203470A2 (hu) | 2003-02-28 |
HUP0203470A3 true HUP0203470A3 (en) | 2005-10-28 |
Family
ID=10862624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203470A HUP0203470A3 (en) | 1999-10-12 | 2000-10-12 | Treatment of fatigue, head injury and stroke |
Country Status (15)
Country | Link |
---|---|
US (1) | US6441038B1 (hu) |
EP (1) | EP1220689B1 (hu) |
AU (1) | AU782656B2 (hu) |
CA (1) | CA2388377C (hu) |
CZ (1) | CZ20021197A3 (hu) |
DE (1) | DE60042598D1 (hu) |
GB (1) | GB2355191A (hu) |
HR (1) | HRP20020309A2 (hu) |
HU (1) | HUP0203470A3 (hu) |
MX (1) | MXPA02003724A (hu) |
NO (1) | NO20021716L (hu) |
NZ (1) | NZ518306A (hu) |
PL (1) | PL354975A1 (hu) |
SK (1) | SK4672002A3 (hu) |
WO (1) | WO2001026623A2 (hu) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK286669B6 (sk) | 1999-07-01 | 2009-03-05 | Pharmacia & Upjohn Company | Použitie opticky čistého (S,S)-reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu periférnej neuropatie |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
AU2003213009A1 (en) * | 2002-02-12 | 2003-09-04 | Cypress Bioscience, Inc. | Methods of treating attention deficit/hyperactivity disorder (adhd) |
US20030176773A1 (en) * | 2002-03-12 | 2003-09-18 | Gendreau Roger Michael | Methods of assessing the level of a subjective symptom |
US20030203055A1 (en) * | 2002-03-15 | 2003-10-30 | Cypress Bioscience, Inc. | Methods of treating visceral pain syndromes |
CN1662231A (zh) * | 2002-04-24 | 2005-08-31 | 柏树生物科学公司 | 包括应激相关障碍在内的功能性躯体障碍的预防与治疗 |
TW200402289A (en) * | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
AU2003231788B2 (en) | 2002-05-17 | 2008-09-11 | Duke University | Method for treating obesity |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
US20070129438A1 (en) * | 2002-07-11 | 2007-06-07 | Yuuichi Murayama | Method for suppressing proliferation of abnormal prion protein |
AU2003284005B2 (en) * | 2002-10-03 | 2009-12-17 | Forest Laboratories Holdings Limited | Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders |
US7704527B2 (en) * | 2002-10-25 | 2010-04-27 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
EP1565182A1 (en) * | 2002-11-19 | 2005-08-24 | Eli Lilly And Company | Treatment of gastrointestinal disorders with duloxetine |
AU2004204825B2 (en) * | 2003-01-13 | 2007-07-19 | Dynogen Pharmaceuticals, Inc. | Method of treating functional bowel disorders |
US20040147510A1 (en) * | 2003-01-13 | 2004-07-29 | Dynogen Pharmaceuticals, Inc. | Method of treating nausea, vomiting, retching or any combination thereof |
FR2851163B1 (fr) | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
WO2004075886A1 (fr) | 2003-02-14 | 2004-09-10 | Pierre Fabre Medicament | Utilisation de l’enantiomere (1s, 2r) du milnacipran pour la preparation d’un medicament |
DE602004007225T2 (de) | 2003-04-04 | 2008-03-06 | Dynogen Pharmaceuticals Inc., Waltham | Methode zur behandlung von erkrankungen der unteren harnwege |
WO2004096201A1 (en) * | 2003-04-29 | 2004-11-11 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
WO2004105690A2 (en) * | 2003-05-23 | 2004-12-09 | Cypress Bioscience, Inc. | Treatment of chronic pain associated with drug or radiation therapy |
GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
DK1708690T3 (en) * | 2003-11-17 | 2016-11-07 | Biomarin Pharm Inc | TREATMENT OF PHENYLKETONURI WITH BH4 |
KR20060128995A (ko) | 2004-01-13 | 2006-12-14 | 듀크 유니버시티 | 체중감량에 영향을 미치는 항경련제와 항정신병 약물의조성물 |
US20060160750A1 (en) * | 2004-01-13 | 2006-07-20 | Krishnan K R R | Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
US20060100205A1 (en) * | 2004-04-21 | 2006-05-11 | Eckard Weber | Compositions for affecting weight loss |
AU2005271574A1 (en) * | 2004-08-03 | 2006-02-16 | Orexigen Therapeutics, Inc. | Combination of bupropion and a second compound for affecting weight loss |
AU2005290980A1 (en) * | 2004-10-01 | 2006-04-13 | Neurocure Ltd | Use of pharmaceutical compositions of lofepramine for the treatment of ADHD, CFS, FM and depression |
EP2436379A1 (en) | 2004-11-17 | 2012-04-04 | BioMarin Pharmaceutical Inc. | Stable tablet formulation |
EP1819340A2 (en) * | 2004-12-08 | 2007-08-22 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of pulmonary hypertension of the newborn |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
EP2135603B1 (en) | 2005-11-22 | 2013-01-02 | Orexigen Therapeutics, Inc. | Compositions and methods for increasing insulin sensitivity |
WO2007089318A2 (en) * | 2005-11-23 | 2007-08-09 | Orexigen Therapeutics, Inc. | Compositions and methods for reducing food cravings |
EP1954316A1 (en) * | 2005-11-28 | 2008-08-13 | Orexigen Therapeutics, Inc. | Methods of treating anxiety disorders |
WO2007067570A1 (en) * | 2005-12-05 | 2007-06-14 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of disease |
US20090306050A1 (en) * | 2006-02-03 | 2009-12-10 | Timothy Dinan | Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
EP2399577A1 (en) | 2006-09-12 | 2011-12-28 | Adolor Corporation | Use of N-containing spirocompounds for the enhancement of cognitive function |
WO2008042773A2 (en) * | 2006-09-29 | 2008-04-10 | Pdxrx, Inc. | Unitary pharmaceutical composition, method, and kit for the treatment or prevention of metabolic or endocrine disorders |
KR20180066272A (ko) | 2006-11-09 | 2018-06-18 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
TWI609702B (zh) | 2006-11-09 | 2018-01-01 | 歐瑞根治療有限公司 | 層狀醫藥調配物 |
US20100009997A1 (en) * | 2007-01-12 | 2010-01-14 | Biomarin Pharmaceutical Inc. | Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug |
EP2139485B1 (en) | 2007-04-11 | 2012-10-17 | BioMarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
CA3208128A1 (en) | 2007-05-01 | 2008-11-13 | Sun Pharmaceutical Industries, Inc. | Morphinan compounds |
MX2010012909A (es) | 2008-05-30 | 2011-02-25 | Orexigen Therapeutics Inc | Metodos para tratamiento de condiciones de grasa visceral. |
US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
EP3090760A1 (en) * | 2008-10-30 | 2016-11-09 | Concert Pharmaceuticals, Inc. | Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
CA2779711C (en) | 2009-11-06 | 2016-11-01 | Forest Laboratories Holding Limited | Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide |
RU2616496C2 (ru) | 2010-01-11 | 2017-04-17 | Ориксиджен Терапьютикс, Инк. | Способы проведения терапии потери веса у пациентов с доминирующей депрессией (варианты) |
US20120289744A1 (en) | 2010-11-03 | 2012-11-15 | Arch Pharmalabs Limited | Process for preparing optically pure milnacipran and its pharmaceutically acceptable salts |
CA2840363A1 (en) * | 2011-06-24 | 2012-12-27 | K-Pax Pharmaceuticals, Inc. | Compositions comprising a central nervous system stimulant and select micronutrients useful in the treatment of chronic fatigue |
US9216178B2 (en) | 2011-11-02 | 2015-12-22 | Biomarin Pharmaceutical Inc. | Dry blend formulation of tetrahydrobiopterin |
RU2493839C1 (ru) * | 2012-02-28 | 2013-09-27 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Способ лечения синдрома хронической усталости |
WO2013184837A1 (en) | 2012-06-06 | 2013-12-12 | Orexigen Therapeutics, Inc. | Methods of treating overweight and obesity |
US20190381056A1 (en) | 2018-06-17 | 2019-12-19 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
US11020402B2 (en) | 2018-10-15 | 2021-06-01 | Axsome Therapeutics, Inc. | Use of reboxetine to treat narcolepsy |
US20200147093A1 (en) | 2018-10-15 | 2020-05-14 | Axsome Therapeutics, Inc. | Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
US20200237875A1 (en) * | 2019-01-30 | 2020-07-30 | Synlev Pharmaceuticals Corporation | Formulations and methods for treatment of fibromyalgia and related myofascial pain disorders |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431670A (en) * | 1980-12-19 | 1984-02-14 | Bernardo Heller | D-Phenylalanine treatment |
US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
PT784476E (pt) * | 1994-10-05 | 2003-03-31 | Cari Loder | Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12 |
GB2297868B (en) | 1995-02-07 | 1999-04-28 | Nokia Mobile Phones Ltd | A shielding device |
JP3128609B2 (ja) | 1996-02-01 | 2001-01-29 | 株式会社小糸製作所 | 車輌用灯具の照射方向制御装置 |
EP0942751B1 (en) * | 1996-07-05 | 2002-09-25 | The WWK Trust | Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
US5765240A (en) * | 1996-07-31 | 1998-06-16 | L&P Property Management Co. | Spring bedding product collapsible in the transverse direction, and method of making it |
GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
GB9618341D0 (en) * | 1996-09-03 | 1996-10-16 | Scotia Holdings Plc | Method of treatment |
-
1999
- 1999-10-12 GB GB9924172A patent/GB2355191A/en not_active Withdrawn
-
2000
- 2000-10-12 WO PCT/GB2000/003926 patent/WO2001026623A2/en active IP Right Grant
- 2000-10-12 MX MXPA02003724A patent/MXPA02003724A/es not_active Application Discontinuation
- 2000-10-12 CZ CZ20021197A patent/CZ20021197A3/cs unknown
- 2000-10-12 EP EP00969670A patent/EP1220689B1/en not_active Expired - Lifetime
- 2000-10-12 HU HU0203470A patent/HUP0203470A3/hu unknown
- 2000-10-12 DE DE60042598T patent/DE60042598D1/de not_active Expired - Lifetime
- 2000-10-12 PL PL00354975A patent/PL354975A1/xx not_active Application Discontinuation
- 2000-10-12 SK SK467-2002A patent/SK4672002A3/sk unknown
- 2000-10-12 US US09/686,629 patent/US6441038B1/en not_active Expired - Fee Related
- 2000-10-12 NZ NZ518306A patent/NZ518306A/en not_active IP Right Cessation
- 2000-10-12 AU AU79328/00A patent/AU782656B2/en not_active Ceased
- 2000-10-12 CA CA2388377A patent/CA2388377C/en not_active Expired - Fee Related
-
2002
- 2002-04-10 HR HR20020309A patent/HRP20020309A2/hr not_active Application Discontinuation
- 2002-04-11 NO NO20021716A patent/NO20021716L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20021716L (no) | 2002-06-10 |
WO2001026623A3 (en) | 2001-06-21 |
PL354975A1 (en) | 2004-03-22 |
SK4672002A3 (en) | 2002-09-10 |
HRP20020309A2 (en) | 2004-02-29 |
CA2388377A1 (en) | 2001-04-19 |
GB9924172D0 (en) | 1999-12-15 |
CZ20021197A3 (cs) | 2002-09-11 |
AU7932800A (en) | 2001-04-23 |
AU782656B2 (en) | 2005-08-18 |
EP1220689B1 (en) | 2009-07-22 |
HUP0203470A2 (hu) | 2003-02-28 |
NZ518306A (en) | 2004-04-30 |
WO2001026623A2 (en) | 2001-04-19 |
GB2355191A (en) | 2001-04-18 |
EP1220689A2 (en) | 2002-07-10 |
CA2388377C (en) | 2011-02-01 |
NO20021716D0 (no) | 2002-04-11 |
DE60042598D1 (de) | 2009-09-03 |
US6441038B1 (en) | 2002-08-27 |
MXPA02003724A (es) | 2003-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9924172D0 (en) | Treatment of fatigue, head injury and stroke | |
HK1054872A1 (en) | Brain, spinal and nerve injury treatment | |
ZA200107315B (en) | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury. | |
HK1034648A1 (en) | Skin care agent, and health and beauty care food. | |
IL128938A0 (en) | Implantable stroke treating device | |
EP1535971A4 (en) | TREATED PIGMENT, ITS USE, AND COMPOUND FOR THE TREATMENT OF PIGMENTS | |
EP1417906A4 (en) | HAIR TREATMENT DEVICE | |
AU2002346504A8 (en) | Therapeutic protein and treatments | |
DE60018393D1 (de) | Oberflächenbehandlungsverfahren und damit behandelter zylinderkopf | |
GB9924370D0 (en) | Sprayable hair treatment products | |
EP1176940A4 (en) | TREATMENT FOR HARDENING THE FINGERNAILS | |
EP1558238A4 (en) | BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA | |
HU9904701D0 (en) | Method and arrangement for relaxing human constitution and improving general condition | |
GB9820631D0 (en) | Hair treatment composition, method and use | |
EP1438431A4 (en) | METHODS OF DIAGNOSING AND TREATING CARDIAC DISEASES | |
EP1408808A4 (en) | METHODS OF DIAGNOSING AND TREATING CARDIAC DISEASES | |
ZA978921B (en) | Therapeutic use of hemoglobin to treat head injury. | |
GB0108564D0 (en) | Skin treatment | |
GB0119164D0 (en) | Skin disease treatment | |
GB9907649D0 (en) | Skin treatment | |
GB9904918D0 (en) | Skin treatment | |
GB2374804B (en) | Skin treatment cream | |
GB9817200D0 (en) | Skin,muscle,connective tissue and bone | |
GB0008327D0 (en) | Skin treatment | |
HU9903061D0 (en) | Method and arrangement for relaxing human constitution and improving general condition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |